NCT06581302 - Magnetic Seizure Therapy for Psychotic Disorders | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions

Psychotic Disorders

Interventions

DEVICE

Magnetic seizure therapy by Magnetic stimulator

The seizure is induced by Magnetic stimulator of MagPro MST(XP)，MagVenture A/S, Farum, Denmark. It is administered in combinations with antipsychotic medications

DRUG

Antipsychotic medications (such as olanzpine, risperidone, aripiprazole, quetiapine, amisulpride, etc)

It mainly includes second-generation antipsychotic medications, such as olanzpine, risperidone, aripiprazole, quetiapine, amisulpride, etc, but except clozapine.

Trial Locations (1)

200030

Shanghai Mental Health Center, Shanghai

All Listed Sponsors

lead

Shanghai Jiao Tong University School of Medicine

OTHER